FDA approves United Therapeutics' drug for treating cancer in children

March 10, 2015 4:51 PM

10 0

(Reuters) - The Food and Drug Administration said it approved United Therapeutics Corp's drug to treat neuroblastoma, a rare cancer that typically occurs in children below 5 years.

Unituxin is the first drug approved to treat high-risk neuroblastoma patients who have a greater chance of tumors recurring or progressing after chemotherapy.

Also read: FDA OKs 2nd gene therapy for blood cancer; 1st for adults

Read more

To category page

Loading...